Leanna Lui
Researcher/author in psychiatry at the University of Toronto
Papers
8 publications
Trials
0 clinical trials
Key Impact
She co-authors systematic reviews and clinical studies on ketamine and esketamine for depression, suicidality, and related adverse effects, contributing to the evidence base in psychedelic and rapid-acting antidepressant research.
Background & Research
Leanna M. W. Lui appears to be a psychiatry researcher based at the University of Toronto and has coauthored multiple papers on ketamine, esketamine, suicidality, and treatment-resistant depression. Her publications include systematic reviews and real-world analyses relevant to rapid-acting antidepressant and psychedelic-adjacent clinical research.
Collaboration Network
24 collaborators· click a node to visit their profile
Full network →Compounds
Topics
Depressive DisordersSuicidalityTreatment-Resistant Depression (TRD)Major Depressive Disorder (MDD)Anxiety DisordersBipolar DisorderNeurocognitive DisordersAlcohol Use Disorder (AUD)Substance Use Disorders (SUD)Equity and EthicsAdolescentsPublic Health, Prevention & Behaviour ChangeChronic PainHealthy VolunteersSafety & Risk ManagementMedicinal Chemistry & Drug DevelopmentHealth Economics & ReimbursementNeuroimaging & Brain MeasuresImmunology & InflammationPTSD